Document is current

Article History

Accepted: 29 October 2024

First Online: 15 November 2024

Declarations

:

: Lu Yang, Xin Yue, Jiayou Zhang, Zejun Wang, and Yongbing Pan are employees of Wuhan Institute of Biological Products Co. Ltd., Wuhan, China.

: This research was funded by the Wuhan Institute of Biological Products Co. Ltd., Wuhan, China.

: This study was conducted in line with the International Conference on Harmonization Standards for Good Clinical Practice, the Helsinki Declaration, and relevant national or international regulatory requirements. The study protocol was reviewed and approved by the hospital ethics committee (approval number: GCP-ICT-2019-28.01, approval date: May 13, 2019) and was registered at NMPA (CXSL1800014).

: Informed consent was obtained from all patients before undergoing any research procedures.

: Not applicable.

: Not applicable.

: The datasets used in this study can be obtained from the corresponding author upon request.

: All authors made a significant contribution to the work reported, whether that was in the conception, study design, execution, acquisition of data, analysis and interpretation or in all these areas; took part in drafting, revising, or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agreed to be accountable for all aspects of the work.